Tina Moore

Yes.

Yes.

Yes.

Yes.

Yes. That's where the PBMs come in. That's where the pharmacy benefits managers screw everything up. I hate them. Kelly and RFK are over here saying it would bankrupt America if we cover this drug for obesity with Medicare. And Trump's over here saying we need to get the drug companies to bring the price down. And I'm in the middle like, hey, PBMs, you're actually the problem.

Yes. That's where the PBMs come in. That's where the pharmacy benefits managers screw everything up. I hate them. Kelly and RFK are over here saying it would bankrupt America if we cover this drug for obesity with Medicare. And Trump's over here saying we need to get the drug companies to bring the price down. And I'm in the middle like, hey, PBMs, you're actually the problem.

Yes. That's where the PBMs come in. That's where the pharmacy benefits managers screw everything up. I hate them. Kelly and RFK are over here saying it would bankrupt America if we cover this drug for obesity with Medicare. And Trump's over here saying we need to get the drug companies to bring the price down. And I'm in the middle like, hey, PBMs, you're actually the problem.

Why does this drug cost $100 or less in other countries in Europe?

Why does this drug cost $100 or less in other countries in Europe?

Why does this drug cost $100 or less in other countries in Europe?

No.

No.

No.

Yeah, it's really, really messed up. And I do think that there's room for these to be incredibly helpful long term and bring down morbidity. And mortality. I mean, gosh, we are really in a pickle here in the US and we've exported it out, but we are between the rates of obesity plus overweight. It's pretty high.

Yeah, it's really, really messed up. And I do think that there's room for these to be incredibly helpful long term and bring down morbidity. And mortality. I mean, gosh, we are really in a pickle here in the US and we've exported it out, but we are between the rates of obesity plus overweight. It's pretty high.

Yeah, it's really, really messed up. And I do think that there's room for these to be incredibly helpful long term and bring down morbidity. And mortality. I mean, gosh, we are really in a pickle here in the US and we've exported it out, but we are between the rates of obesity plus overweight. It's pretty high.

I say the same. And my argument to the folks who are so against it, like some of these big influencers who are just so, so against it, I know these folks are on compounded hormones.

I say the same. And my argument to the folks who are so against it, like some of these big influencers who are just so, so against it, I know these folks are on compounded hormones.

I say the same. And my argument to the folks who are so against it, like some of these big influencers who are just so, so against it, I know these folks are on compounded hormones.

I know they're on other peptides. So I'm like, hmm, this is interesting. I could make a pretty sound argument that a 40-year-old woman who needs a compounded or even just a low dose of thyroid medication, yes, give it to her. Fine. That's great for subclinical hypothyroidism. Subclinical hypothyroidism untreated, we have data to show significant increased risk for